Cargando…

Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies

Post-Covid Olfactory Dysfunction (PCOD) is characterized by olfactory abnormalities, hyposmia, and anosmia, which are among the most often enduring symptoms in individuals who have recovered from SARS-CoV-2 infection. This disorder has been reported to persist in subsets of patients well after 12 mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capra, Anna Paola, Ardizzone, Alessio, Crupi, Lelio, Calapai, Fabrizio, Campolo, Michela, Cuzzocrea, Salvatore, Esposito, Emanuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452638/ https://www.ncbi.nlm.nih.gov/pubmed/37626685 http://dx.doi.org/10.3390/biomedicines11082189

Ejemplares similares

The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury
por: Siracusa, Rosalba, et al.
Publicado: (2015)

Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice
por: Impellizzeri, Daniela, et al.
Publicado: (2013)

Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
por: Cordaro, Marika, et al.
Publicado: (2020)

Co-Ultramicronized Palmitoylethanolamide/Luteolin Promotes Neuronal Regeneration after Spinal Cord Injury
por: Crupi, Rosalia, et al.
Publicado: (2016)

Serum Pentraxin 3 as Promising Biomarker for the Long-Lasting Inflammatory Response of COVID-19
por: Capra, Anna Paola, et al.
Publicado: (2023)

Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man
por: Caltagirone, Carlo, et al.
Publicado: (2015)

The Prognostic Value of Pentraxin-3 in COVID-19 Patients: A Systematic Review and Meta-Analysis of Mortality Incidence
por: Capra, Anna Paola, et al.
Publicado: (2023)

Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
por: Paterniti, Irene, et al.
Publicado: (2013)

A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
por: Paterniti, Irene, et al.
Publicado: (2013)

Erratum to: A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
por: Paterniti, Irene, et al.
Publicado: (2016)

Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies
por: Ardizzone, Alessio, et al.
Publicado: (2023)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain
por: Ardizzone, Alessio, et al.
Publicado: (2021)

Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial
por: Di Stadio, Arianna, et al.
Publicado: (2023)

Treatment with Luteolin Improves Lipopolysaccharide-Induced Periodontal Diseases in Rats
por: Casili, Giovanna, et al.
Publicado: (2020)

Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis
por: Filippone, Alessia, et al.
Publicado: (2023)

Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets
por: Peritore, Alessio Filippo, et al.
Publicado: (2019)

Efficacy of a Novel Therapeutic, Based on Natural Ingredients and Probiotics, in a Murine Model of Multiple Food Intolerance and Maldigestion
por: Ardizzone, Alessio, et al.
Publicado: (2022)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing
por: Gugliandolo, Enrico, et al.
Publicado: (2020)

Neurofibromatosis: New Clinical Challenges in the Era of COVID-19
por: Ardizzone, Alessio, et al.
Publicado: (2022)

Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness
por: Bova, Valentina, et al.
Publicado: (2022)

The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats
por: Siracusa, Rosalba, et al.
Publicado: (2020)

Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury
por: Campolo, Michela, et al.
Publicado: (2021)

Oral Supplementation with Ultramicronized Palmitoylethanolamide for Joint Disease and Lameness Management in Four Jumping Horses: A Case Report
por: Gugliandolo, Enrico, et al.
Publicado: (2020)

New Insights into the Mechanism of Ulva pertusa on Colitis in Mice: Modulation of the Pain and Immune System
por: Ardizzone, Alessio, et al.
Publicado: (2023)

Absence of TLR4 Reduces Neurovascular Unit and Secondary Inflammatory Process after Traumatic Brain Injury in Mice
por: Ahmad, Akbar, et al.
Publicado: (2013)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
por: Petrosino, Stefania, et al.
Publicado: (2018)

Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
por: Peritore, Alessio Filippo, et al.
Publicado: (2021)

Efficacy of the Radical Scavenger, Tempol, to Reduce Inflammation and Oxidative Stress in a Murine Model of Atopic Dermatitis
por: Ardizzone, Alessio, et al.
Publicado: (2023)

A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome
por: Filippone, Alessia, et al.
Publicado: (2022)

To Go Where Nature Leads: Focus on Palmitoylethanolamide and Related ALIAmides as Innovative Approach to Neuroinflammatory and Pain-Related Disease States in Honor of Doctor Francesco Della Valle
por: Cuzzocrea, Salvatore, et al.
Publicado: (2023)

Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
por: D’Amico, Ramona, et al.
Publicado: (2021)

Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis
por: Ardizzone, Alessio, et al.
Publicado: (2021)

H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol
por: Ardizzone, Alessio, et al.
Publicado: (2022)

A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo
por: Paterniti, Irene, et al.
Publicado: (2022)

A Systematic Review and Meta-Analysis of the Association between the FV H1299R Variant and the Risk of Recurrent Pregnancy Loss
por: Capra, Anna Paola, et al.
Publicado: (2022)

Dimethyl Fumarate (DMF) Alleviated Post-Operative (PO) Pain through the N-Methyl-d-Aspartate (NMDA) Receptors
por: Casili, Giovanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t2kqg9809q7e4f0ajti8bejlls